In this study, the imaging characteristics of cetuximab-IRDye800CW were systematically validated in two well-established EGFR-overexpressing colorectal cancer cell lines (LS174T and SW948) as well as in an EGFR-high PDX model. Here, EGFR is linked to colorectal cancer.